The Current Ratio as of December 2025 (TTM) for Genscript Biotech Corporation (GNNSF) is 1.96

According to Genscript Biotech Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 1.96. This represents a change of -42.31% compared to the average of 3.40 of the last 4 quarters.

Genscript Biotech Corporation (GNNSF) Historical Current Ratio (quarterly & annually)

How has GNNSF Current Ratio performed in the past?

The mean historical Current Ratio of Genscript Biotech Corporation over the last ten years is 3.45. The current 1.96 Current Ratio has changed 5.57% with respect to the historical average. Over the past ten years (40 quarters), GNNSF's Current Ratio was at its highest in in the June 2023 quarter at 5.64. The Current Ratio was at its lowest in in the June 2013 quarter at 0.

Genscript Biotech Corporation (GNNSF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Genscript Biotech Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genscript Biotech Corporation (GNNSF) Average Current Ratio

How has GNNSF Current Ratio performed in the past?

The current Current Ratio of Genscript Biotech Corporation (GNNSF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genscript Biotech Corporation (GNNSF) Current Ratio vs. Peers

How is GNNSF’s Current Ratio compared to its peers?

Genscript Biotech Corporation’s Current Ratio is greater than Shanghai Junshi Biosciences Co., Ltd. (1.62), less than Laboratorios Farmaceuticos Rovi, S.A. (2.77), less than InnoCare Pharma Limited (7.66), less than Camurus AB (publ) (10.61), less than ALK-Abelló A/S (2.24), less than Zealand Pharma A/S (15.09), less than Siegfried Holding AG (2.91), greater than Carl Zeiss Meditec AG (0), greater than Welcia Holdings Co., Ltd. (1.15), greater than Sumitomo Pharma Co., Ltd. (1.11),

Build a custom stock screener for Genscript Biotech Corporation (GNNSF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genscript Biotech Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genscript Biotech Corporation (GNNSF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genscript Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.